![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1401, 2003-01, pp. : 5-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Diabetic complications inflate costs in the UK, the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 425, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Costs of Irritable Bowel Syndrome in the UK and US
PharmacoEconomics, Vol. 24, Iss. 1, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Atorvastatin and Diabetic Vascular Complications
Current Pharmaceutical Design, Vol. 12, Iss. 12, 2006-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
ACE2 and Diabetic Complications
Current Pharmaceutical Design, Vol. 13, Iss. 26, 2007-09 ,pp. :